DK0386734T3 - Immunogene regioner på E-7-proteinet af humant papillomavirus type 16 - Google Patents

Immunogene regioner på E-7-proteinet af humant papillomavirus type 16

Info

Publication number: DK0386734T3
Authority: DK; Denmark
Prior art keywords: protein; human papillomavirus; papillomavirus type; immunogenic regions; hpv
Prior art date: 1989-03-10

Application number

DK90104353.9T

Other languages

Danish (da)

English (en)

Inventor

Dusan Dr Bartsch

Lutz Dr Prof Gissmann

Martin Mueller

Original Assignee

Behringwerke Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-10

Filing date

1990-03-07

Publication date

1996-02-05

1990-03-07 Application filed by Behringwerke Ag filed Critical Behringwerke Ag

1996-02-05 Application granted granted Critical

1996-02-05 Publication of DK0386734T3 publication Critical patent/DK0386734T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Virology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Wood Science & Technology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK90104353.9T 1989-03-10 1990-03-07 Immunogene regioner på E-7-proteinet af humant papillomavirus type 16 DK0386734T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3907721A DE3907721A1 (de)	1989-03-10	1989-03-10	Immunogene regionen auf dem e7-protein des humanen papillomvierus typ 16

Publications (1)

Publication Number	Publication Date
DK0386734T3 true DK0386734T3 (da)	1996-02-05

Family

ID=6375965

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90104353.9T DK0386734T3 (da)	1989-03-10	1990-03-07	Immunogene regioner på E-7-proteinet af humant papillomavirus type 16

Country Status (12)

Country	Link
US (1)	US5547846A (es)
EP (1)	EP0386734B1 (es)
JP (1)	JP3056502B2 (es)
KR (1)	KR0164215B1 (es)
AT (1)	ATE128144T1 (es)
AU (1)	AU624485B2 (es)
CA (1)	CA2011878C (es)
DE (2)	DE3907721A1 (es)
DK (1)	DK0386734T3 (es)
ES (1)	ES2078255T3 (es)
IE (1)	IE67798B1 (es)
PT (1)	PT93393B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0451550A3 (en) *	1990-03-20	1991-11-06	Behringwerke Aktiengesellschaft	Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
US5932412A (en) *	1990-05-11	1999-08-03	Euro-Diagnostica Ab	Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
SE9001705D0 (sv) *	1990-05-11	1990-05-11	Medscand Ab	Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
US6183745B1 (en)	1990-12-12	2001-02-06	The University Of Queensland	Subunit papilloma virus vaccine and peptides for use therein
DE69232963T2 (de) *	1991-07-13	2004-03-04	Dade Behring Marburg Gmbh	Verwendung von HPV-16 E6 und E7-Gen gewonnen Peptiden für den diagnostischen Zweck
IL105554A (en) *	1992-05-05	1999-08-17	Univ Leiden	Peptides of human papillomavirus for use in preparations elicit a human T cell response
GB9717953D0 (en)	1997-08-22	1997-10-29	Smithkline Beecham Biolog	Vaccine
DE19737409A1 (de)	1997-08-27	1999-03-04	Medigene Ag	Diagnosekit für Hauttest und Verfahren zur Durchführung desselben
US6013258A (en) *	1997-10-09	2000-01-11	Zycos Inc.	Immunogenic peptides from the HPV E7 protein
US6183746B1 (en) *	1997-10-09	2001-02-06	Zycos Inc.	Immunogenic peptides from the HPV E7 protein
DE19819476C1 (de) *	1998-04-30	2000-01-05	Deutsches Krebsforsch	Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins
FR2781158B1 (fr) *	1998-07-15	2002-12-13	Vacs Internat	Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications
DE19925235A1 (de)	1999-06-01	2000-12-07	Medigene Ag	Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925199A1 (de) *	1999-06-01	2000-12-07	Medigene Ag	Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
US6641994B2 (en)	1999-08-25	2003-11-04	Pharmacia & Upjohn Company	Methods of identifying anti-viral agents
US6200746B1 (en)	1999-08-25	2001-03-13	Pharmacia & Upjohn Company	Methods of identifying anti-viral agents
US20050100928A1 (en) *	1999-09-16	2005-05-12	Zycos Inc., A Delaware Corporation	Nucleic acids encoding polyepitope polypeptides
US8128922B2 (en)	1999-10-20	2012-03-06	Johns Hopkins University	Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
GB0018050D0 (en) *	2000-07-21	2000-09-13	Norchip As	Detection of human papillomavirus mRNA
US7318928B2 (en) *	2000-08-01	2008-01-15	The Johns Hopkins University	Molecular vaccine linking intercellular spreading protein to an antigen
EP1363938B1 (en) *	2000-08-03	2013-12-11	Johns Hopkins University	Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
EP1425039A4 (en)	2001-03-23	2005-02-02	Us Gov Health & Human Serv	PEPTIDES THAT GIVE AN IMMUNE REACTION WITH THE HUMAN PAPILLOMA VIRUS
GB0120938D0 (en) *	2001-08-29	2001-10-17	Norchip As	Detection of human papillomavirus E7 mRNA
AU2003284239B2 (en) *	2002-10-21	2008-08-21	Eisai Inc.	Compositions and methods for treating human papillomavirus-mediated disease
EP1644048B1 (en) *	2003-05-05	2015-04-29	Johns Hopkins University	Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
CA2594040A1 (en) *	2005-01-06	2006-07-13	The Johns Hopkins University	Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
WO2006081323A2 (en) *	2005-01-26	2006-08-03	The Johns Hopkins University	Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
US20100330105A1 (en) *	2006-08-22	2010-12-30	John Hopkins University	Anticancer Combination Therapies
US9085638B2 (en)	2007-03-07	2015-07-21	The Johns Hopkins University	DNA vaccine enhancement with MHC class II activators
US20080260765A1 (en) *	2007-03-15	2008-10-23	Johns Hopkins University	HPV DNA Vaccines and Methods of Use Thereof
CU23674A1 (es)	2007-07-31	2011-05-27	Ct Ingenieria Genetica Biotech	Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica
US20090285861A1 (en) *	2008-04-17	2009-11-19	Tzyy-Choou Wu	Tumor cell-based cancer immunotherapeutic compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4777239A (en) *	1986-07-10	1988-10-11	The Board Of Trustees Of The Leland Stanford Junior University	Diagnostic peptides of human papilloma virus
DE3722967A1 (de) *	1987-07-11	1989-01-19	Behringwerke Ag	Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung
FR2641081A1 (es) *	1988-12-23	1990-06-29	Medgenix Group
JP2791685B2 (ja) *	1989-06-08	1998-08-27	寳酒造株式会社	パピローマウイルスの検出方法
EP0451550A3 (en) *	1990-03-20	1991-11-06	Behringwerke Aktiengesellschaft	Seroreactive epitopes of human papillomavirus (hpv) 16 proteins

1989
- 1989-03-10 DE DE3907721A patent/DE3907721A1/de not_active Withdrawn
1990
- 1990-03-07 DK DK90104353.9T patent/DK0386734T3/da active
- 1990-03-07 AT AT90104353T patent/ATE128144T1/de not_active IP Right Cessation
- 1990-03-07 EP EP90104353A patent/EP0386734B1/de not_active Expired - Lifetime
- 1990-03-07 ES ES90104353T patent/ES2078255T3/es not_active Expired - Lifetime
- 1990-03-07 DE DE59009669T patent/DE59009669D1/de not_active Expired - Fee Related
- 1990-03-08 AU AU51104/90A patent/AU624485B2/en not_active Ceased
- 1990-03-09 KR KR1019900003101A patent/KR0164215B1/ko not_active IP Right Cessation
- 1990-03-09 IE IE85490A patent/IE67798B1/en not_active IP Right Cessation
- 1990-03-09 JP JP2059801A patent/JP3056502B2/ja not_active Expired - Fee Related
- 1990-03-09 PT PT93393A patent/PT93393B/pt not_active IP Right Cessation
- 1990-03-09 CA CA002011878A patent/CA2011878C/en not_active Expired - Fee Related
1994
- 1994-08-16 US US08/292,169 patent/US5547846A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2011878A1 (en)	1990-09-10
ATE128144T1 (de)	1995-10-15
CA2011878C (en)	2000-05-02
IE67798B1 (en)	1996-05-01
US5547846A (en)	1996-08-20
JP3056502B2 (ja)	2000-06-26
DE59009669D1 (de)	1995-10-26
KR0164215B1 (ko)	1999-01-15
IE900854L (en)	1990-09-10
EP0386734A3 (de)	1992-03-04
PT93393A (pt)	1990-11-07
KR900013979A (ko)	1990-10-22
AU5110490A (en)	1990-09-13
EP0386734A2 (de)	1990-09-12
EP0386734B1 (de)	1995-09-20
PT93393B (pt)	1997-01-31
DE3907721A1 (de)	1990-09-20
JPH02289600A (ja)	1990-11-29
ES2078255T3 (es)	1995-12-16
AU624485B2 (en)	1992-06-11

Publication	Publication Date	Title
DK0386734T3 (da)	1996-02-05	Immunogene regioner på E-7-proteinet af humant papillomavirus type 16
ATE141946T1 (de)	1996-09-15	Hiv-2-virusvarianten
DK1021547T3 (da)	2007-04-23	Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
ES8500322A1 (es)	1984-10-01	Un metodo de modificar un virus para conferirle una nueva funcion biologica.
DE3788691D1 (de)	1994-02-17	Verhütung von Fusariumkrankheiten und Mikroorganismen dafür.
NO922953L (no)	1992-09-04	Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
WO1996029413A3 (en)	1996-11-28	Dna encoding human papilloma virus type 18
FI890116A (fi)	1989-07-12	Icke-reverterande rna-virus.
ATE103980T1 (de)	1994-04-15	Das f-protein vom aids-virus enthaltender impfstoff.
DE69125066D1 (de)	1997-04-17	cDNS-Sequenz und Detektion des Hepatitis C-Virus
DK1040191T3 (da)	2005-12-19	RANTES-mutanter og terapeutiske anvendelser heraf
ATE195072T1 (de)	2000-08-15	Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DK0393530T3 (da)	1995-05-22	5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
PT1149901E (pt)	2006-08-31	Mutantes de pestivirus e vacinas contendo os mesmos
FI893346A0 (fi)	1989-07-10	Icke-reverterande rna-virus.
HUP0003511A2 (hu)	2001-02-28	Hepatitisz-B-vírus polipeptidek
DE59208855D1 (de)	1997-10-09	Verwendung von Aminoalkyl-substituierten 5,6-Dihydro-dibenz(b,e)azepin-6,11-dion-11-oximen als antivirale Mittel
UA6146A1 (uk)	1994-12-29	1,1-біс-[2-(2,7-діацетоксифлуорениліден-9-гідразоно)тиазолідон-4-іл-5]-о-нітрофенилметан, що виявляє антивірусну дію відносно рнк- та днк- вмістних вірусів
DE69111209D1 (de)	1995-08-17	Herstellung und Reinigung von 3,4-Dihydrocumarin.
ATE81454T1 (de)	1992-10-15	Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.